Cargando…
Palmar–plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report
An 11-year-old neutered male Miniature Poodle with a stage 3 apocrine gland adenocarcinoma was started on chemotherapy with toceranib phosphate after surgery. Beginning on day 10 of toceranib, the dog’s foot pads became erythematous and hyperkeratinized. The dog complained of pain, inability to walk...
Autores principales: | Kim, Eunjoo, Kim, Sung-Soo, Ryu, Min-Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694368/ https://www.ncbi.nlm.nih.gov/pubmed/37904638 http://dx.doi.org/10.4142/jvs.23163 |
Ejemplares similares
-
Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
por: Heaton, Caitlin M., et al.
Publicado: (2020) -
Paclitaxel-Induced Palmar-Plantar Erythrodysesthesia
por: Wahab, Ahsan, et al.
Publicado: (2020) -
Docetaxel induced severe palmar plantar erythrodysesthesia
por: Kharmoum, Saoussane, et al.
Publicado: (2018) -
Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment
por: Farr, Katherina Podlekareva, et al.
Publicado: (2011) -
Palmar-plantar erythrodysesthesia: An uncommon adverse effect of everolimus
por: Arora, Shalabh, et al.
Publicado: (2016)